Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Typical Guy CEO , tells shareholders after it happens
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Post by SamV21on Feb 10, 2023 7:40pm
705 Views
Post# 35280921

Typical Guy CEO , tells shareholders after it happens

Typical Guy CEO , tells shareholders after it happens Nothing changes , except the price keeps dropping , I called .02 cents this week and here we are , small lot traded at the bell for .025 , Tetra has not finished dropping yet ! we will see .015 soon . No news , no product , no revenue payments coming due to Panag Pharma very soon. Its all just an over paid Guy wage and it needs to stop ! Tetra could have had revenue years ago if Guy had not blown all our money on his dream wheel and being over paid for winging it for 5 years now . He is a lab teck worth 100,000 a year at best , NOT A CEO ,Guy needs to go ! He hasn't a clue when it comes to financing , he is a scientist and could care less about shareholders as long as he collects his 500,000.00 a year its all good.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities